Cayston (aztreonam lysine) / Gilead 
Welcome,         Profile    Billing    Logout  

5 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cayston (aztreonam lysine) / Gilead
2013-004295-35: Lung Clearance Index as an OUTcome parameter to detect the efficacy f Aztreonam Lysine Inhalation in cystic fibrosis patients with near normal spirometry - an observational proof-of concept study

Ongoing
4
15
Europe
Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler, Colistin Forest - Trockenstechampullen mit Lösungsmittel, Tobi, Powder and solvent for nebuliser solution, Nebuliser solution, Cayston 75 mg Pulver und Lösungsmittel zur Herstellung einer Lösung für einen Vernebler, Colistin Forest - Trockenstechampullen mit Lösungsmittel, TOBI 300 mg/5 ml - Lösung für einen Vernebler
Medical University Innsbruck - Department für Kinder- und Jugendheilkunde (Pädiatrie III), Gilead Sciences
Chronic lung P. Aeruginosa Infection, chronic lung infection, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2016-002832-34: The use of an inhaled antibiotic called Cayston to treat acute chest infections in people with CF

Ongoing
4
16
Europe
Cayston, Inhalation powder, Cayston
Liverpool Heart & Chest Hospital, Gilead Sciences
Cystic fibrosis, Cystic fibrosis - a genetic disorder that results in thicker than usual bodily secretions, particularly affecting the lungs making them prone to infections and resulting in progressive lung disease., Diseases [C] - Respiratory Tract Diseases [C08]
 
 
2018-003865-32: Clinical trial to evaluate the efficacy, safety and pharmacokinetics profile of nebulized Aztreonam Lysine (AZLI) for prevention of Gram negative pneumonia in heavily colonized mechanically ventilated patients Ensayo clínico para valorar el perfil de eficacia, seguridad y farmacocinética de Aztreonam lisina nebulizada (AZLI) para la prevención de la neumonía gram negativo en pacientes con ventilación mecánica altamente colonizados

Not yet recruiting
2
20
Europe
Inhalation solution, Cayston
Alejandro Rodriguez Oviedo ‐ Critical Care Department – Hospital Universitario de Tarragona Joan XXIII, Institut d'Investigació Sanitària Pere Virgili (IISPV)
Gram negative pneumonia in heavily colonized mechanically ventilated patients Neumonia gram negativo en pacientes con alta colonización y ventilación mecánica., Gram negative pneumonia in heavily colonized mechanically ventilated patients. Neumonia gram negativo en pacientes con alta colonización y ventilación mecánica., Diseases [C] - Respiratory Tract Diseases [C08]
 
 
2018-001590-24: Value of inhaled treatment with Aztreonam lysine in bronchiectasis- VITAL- BE

Not yet recruiting
2
100
Europe
Cayston, Powder for nebuliser solution, Cayston
University of Dundee, NHS Tayside, Gilead Sciences Europe Ltd,
Bronchiectasis, Bronchiectasis, which is a long-term condition that occurs when the small airways in the lungs become damaged and filled with phlegm, leading to frequent chest infections., Diseases [C] - Respiratory Tract Diseases [C08]
 
 
VitalBE, NCT03696290: Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis

Recruiting
2
100
Europe
Aztreonam lysine, Cayston, Placebo, Lactose monohydrate
University of Dundee, Gilead Sciences
Bronchiectasis Adult
09/25
09/25

Download Options